NCT00006101 2018-05-14Eflornithine in Treating Patients At High Risk of Developing Prostate CancerUniversity of California, IrvinePhase 2 Completed76 enrolled 7 charts
NCT00086736 2013-11-19Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical ProstatectomyUniversity of Alabama at BirminghamPhase 2 Completed34 enrolled